Skip to content
Artwork for Oxford+
BusinessInvestingEntrepreneurship

Oxford+

Susannah de Jager

Welcome to Oxford+, the podcast series that explores the myths and truths of the Oxford investing landscape hosted by Susannah de Jager. Since moving to Oxford, Susannah has collaborated with experts, entrepreneurs, and government to shape the conversation around domestic scale-up capital. Oxford+ aims to inform, inspire, and connect. We'll talk to Founders, investors, academics, politicians, and facilitators and explore how Oxford is open for business.

Play
  • 24 episodes
  • weekly
  • Avg 24 min
  • English
Counted on this page — what you have heard stays on this device, so it is not something the list can be paged by.
  • #1
    June 30 · 2 min

    Introducing the Ethics & Innovation Miniseries

    How do we ensure technology serves society rather than society becoming subject to technology? And perhaps most importantly, what does progress actually mean? In this special Oxford+ Miniseries, we're going to speak to leading academics, policymakers, entrepreneurs, and practitioners working at the intersection of ethics, technology, and society. Together, we're going to explore questions including how should we govern powerful new technologies? What does human flourishing look like in the age of AI? How is technology shaping childhood, relationships, and mental health? And how can innovation ecosystems ensure that prosperity is shared more broadly? The aim of this miniseries is not to provide definitive answers, rather to help all of us ask better questions. Because the future is not something that simply happens to us, it's something we can choose to build. Ethics and Innovation is proudly sponsored by Equinox, Equitable Innovation Oxford. Equinox brings together leaders from across business, academia, local government, and civil society to ensure that the benefits of Oxford's remarkable innovation ecosystem are shared more widely across communities helping to create more inclusive, sustainable, and equitable future for the region. Susannah de Jager: Susannah is a seasoned professional with over 15 years of experience in UK asset management. She has worked closely with industry experts, entrepreneurs, and government officials to shape the conversation around domestic scale-up capital. Connect with Susannah on LinkedIn and Subscribe to the Oxford+ Newsletter for Exclusive Content The Ethics & Innovation Miniseries is hosted by Susannah de Jager and supported by Equinox. Produced and Edited by Story Ninety-Four in Oxford.

    • Transcript
  • June 23 · 2 min

    Season Four Wrap and a Look Ahead to Ethics, AI and Season Five

    What changes when an innovation ecosystem stops talking about problems and starts talking about solutions? In this wrap of Season Four, Oxford+ host Susannah de Jager reflects on a clear shift in rhetoric across the series, from missing pieces of the puzzle to a real sense of momentum in Oxford and the wider UK. She points to initiatives like Equinox, Equitable Innovation Oxford, and the inaugural Oxford Tech Week as signs of an ecosystem finally galvanising itself and becoming easier to engage with. The timing fits a buoyant national picture: UK startup funding reached $7.8 billion in the first quarter of 2026, up 60 per cent year on year, the strongest start to a year since 2022, according to HSBC Innovation Banking and Dealroom. Susannah also looks ahead, previewing a summer Ethics and Innovation miniseries on how AI should be shaped for societies, children and workforces, and a Season Five from September featuring names including Gordon Sanghera and Hermann Hauser. Susannah de Jager: Susannah is a seasoned professional with over 15 years of experience in UK asset management. She has worked closely with industry experts, entrepreneurs, and government officials to shape the conversation around domestic scale-up capital. Connect with Susannah on LinkedIn and Subscribe to the Oxford+ Newsletter for Exclusive Content Oxford+ is hosted by Susannah de Jager and supported by Mishcon de Reya, HSBC Innovation Banking, and James Cowper Kreston. Produced and Edited by Story Ninety-Four in Oxford.

    • Transcript
  • S4 · E10
    June 16 · 6 min

    Oxford+ in Brief with Ceri Morgan, Partner at Dalloway Partners

    How should we measure success in the place trying to scale Britain's best science? In this Oxford+ in Brief, Dr Ceri Morgan takes on the same four quick-fire questions every guest faces. She reflects on what success would mean after two decades spent at arm's length in investment banking, the advice she would give anyone entering the Oxford ecosystem, and what the city does brilliantly yet struggles with: it brings you face to face with astonishing, modest people, but connects them far too rarely. Looking ahead to 2050, Ceri wants Oxford closer to the Boston benchmark, with more companies scaling outside the university and acquirers reinvesting locally rather than draining talent abroad. Her timing is apt: UK university spin-outs have nearly tripled in value to £49 billion since 2020, with activity now spreading beyond the golden triangle. From mentorship and the Lamb and Flag to a magic-wand investor database, this is a short, candid window into how a natural connector thinks. Ceri Morgan: Dr Ceri Morgan is a Partner at Dalloway Partners, the advisory firm founded in 2025 by Vanessa Colomar and Helen James to help foundational science and first-time founders scale at speed. A medical doctor by training, she practised in cardiology and trauma medicine before moving into the City, where she spent more than two decades in healthcare and life sciences investment banking, building and leading top-ranked life science teams at firms including KBC Peel Hunt and Deutsche Bank and advising companies such as Oxford Nanopore and IP Group. Most recently she was Head of Late Stage Portfolio at Oxford Science Enterprises, and she is a Senior Advisor to LifeScience ORG. Based in Oxford, she also sits on a London hospital patient advisory group, drawing on her own experience as a cancer patient to push for stronger patient advocacy. Connect with Ceri on LinkedIn Susannah de Jager: Susannah is a seasoned professional with over 15 years of experience in UK asset management. She has worked closely with industry experts, entrepreneurs, and government officials to shape the conversation around domestic scale-up capital. Connect with Susannah on LinkedIn and Subscribe to the Oxford+ Newsletter for Exclusive Content Oxford+ is hosted by Susannah de Jager and supported by Mishcon de Reya, HSBC Innovation Banking, and James Cowper Kreston. Produced and Edited by Story Ninety-Four in Oxford.

    • Transcript
  • S4 · E10
    June 9 · 38 min

    Recycling Capital and Talent in Oxford's Innovation Economy

    How should we value a healthcare system that frustrates the very innovators trying to improve it? In this episode of Oxford+, host Susannah de Jager speaks with Dr Ceri Morgan, a doctor turned healthcare investment banker turned patient, about her three careers and what they reveal about UK life sciences. Ceri explains why, for years, companies pitching an NHS-first strategy were handed close to a zero valuation, and why the UK's thin life sciences public market has pushed founders towards private capital and trade sales. Her move to Dalloway Partners marks a third act focused on the non-scientific side of scaling: mentoring founders, opening up investor networks and building Oxford's ecosystem. The timing matters. After UK biotech raised just £1.8 billion in 2025, early 2026 figures show venture funding rebounding, with £516 million raised in the first quarter. From recycling capital and talent to being your own patient advocate, this is a candid conversation about fixing the structures around brilliant British science. (00:00) - Welcome to Oxford+ (01:23) - A Doctor's Path into the City (03:34) - Building a Life Sciences Banking Team (06:31) - Twenty Years Advising Science Companies (08:35) - A Third Career and a New Mission (10:24) - Why the NHS Earns a Zero Valuation (11:53) - The Shrinking Life Sciences Public Market (14:50) - Inside Dalloway Partners (16:48) - The Non-Scientific Side of Scaling (21:53) - Treating Oxford as One Ecosystem (25:54) - Female Health, Storytelling and Open Networks (32:06) - Being Your Own Patient Advocate Ceri Morgan: Dr Ceri Morgan is a Partner at Dalloway Partners, the advisory firm founded in 2025 by Vanessa Colomar and Helen James to help foundational science and first-time founders scale at speed. A medical doctor by training, she practised in cardiology and trauma medicine before moving into the City, where she spent more than two decades in healthcare and life sciences investment banking, building and leading top-ranked life science teams at firms including KBC Peel Hunt and Deutsche Bank and advising companies such as Oxford Nanopore and IP Group. Most recently she was Head of Late Stage Portfolio at Oxford Science Enterprises, and she is a Senior Advisor to LifeScience ORG. Based in Oxford, she also sits on a London hospital patient advisory group, drawing on her own experience as a cancer patient to push for stronger patient advocacy. Connect with Ceri on LinkedIn Susannah de Jager: Susannah is a seasoned professional with over 15 years of experience in UK asset management. She has worked closely with industry experts, entrepreneurs, and government officials to shape the conversation around domestic scale-up capital. Connect with Susannah on LinkedIn and Subscribe to the Oxford+ Newsletter for Exclusive Content Oxford+ is hosted by Susannah de Jager and supported by Mishcon de Reya, HSBC Innovation Banking, and James Cowper Kreston. Produced and Edited by Story Ninety-Four in Oxford.

    • Transcript
    • Chapters
Showing 21–24 of 24 episodes